Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Early Biomarkers for ARthritic PAIN to Guide Improved Treatments for Arthritis (ARPAIN) Study

NCT03533569 is registered in ClinicalTrials.gov with St George's, University of London as lead sponsor.

NCT NCT03533569
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03533569 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Early Biomarkers for ARthritic PAIN to Guide Improved Treatments for Arthritis (ARPAIN) Study
Lead sponsor
St George's, University of London
Phase
Observational
Overall status
Unknown status
Start date
April 2, 2018
Completion date
April 2, 2022
Enrollment
150 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

osteoarthritis, knee, psoriatic arthritis, rheumatoid arthritis, spondyloarthritis